Skip to main content
Equibles

AMERICAN CENTURY COMPANIES INC

Position in LYEL — Lyell Immunopharma, Inc.

CIK 748054 KANSAS CITY, MO
Back to LYEL Full portfolio

Position in LYEL

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$344,787
+$24,409 QoQ
Shares Held
24,540
+53.7% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 87 holders
Holding Since
Sep 2022
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AMERICAN CENTURY COMPANIES INC holds $3,618,743,392 across 179 Biotechnology names. LYEL ranks #135 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 1,853,956 $558,096,374
2 ASND
Ascendis Pharma A/S
 1,400,575 $373,561,364
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 580,901 $288,550,953
4 ARGX
Argenx SE
 173,193 $160,683,269
5 IONS
Ionis Pharmaceuticals Inc
 1,947,076 $154,383,656
6 EXEL
Exelixis, Inc.
 1,791,664 $97,484,438
7 HRMY
Harmony Biosciences Holdings, Inc.
 2,539,512 $92,463,631
8 GPCR
Structure Therapeutics Inc.
 1,682,179 $90,282,546

All Filings in LYEL

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $344,787 24,540
2026-03-31 $320,378 15,971
2024-06-30 $405,166 279,425
2024-03-31 $527,780 236,673
2023-12-31 $282,163 145,445
2023-09-30 $177,797 120,951
2023-06-30 $254,775 80,118
2023-03-31 $111,859 47,398
2022-12-31 $137,519 39,631
2022-09-30 $191,576 26,136